OptiBiotix Health (LON:OPTI – Get Free Report) announced its earnings results on Thursday. The company reported GBX (1.52) earnings per share (EPS) for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.
OptiBiotix Health Stock Down 9.1%
OPTI stock opened at GBX 6 on Thursday. OptiBiotix Health has a twelve month low of GBX 4.50 and a twelve month high of GBX 12.25. The company has a market cap of £6.20 million, a PE ratio of -1.56 and a beta of 1.82. The business’s 50-day simple moving average is GBX 5.80 and its 200 day simple moving average is GBX 5.74.
OptiBiotix Health Company Profile
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Further Reading
- Five stocks we like better than OptiBiotix Health
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
